Elevated Concentrations of Kynurenic Acid, a Tryptophan Derivative, in Dense Nuclear Cataracts

REFERENCES

• Truscott R JW. Age related nuclear cataract: a lens transport problem. Ophthalmic Res. 2000; 32: 185–194
   PubMed Web of Science ®Google Scholar
• Aquilina J A, Carver J A, Truscott R J. Oxidation products of 3-hydroxykynurenine bind to lens proteins: relevance for nuclear cataract. Exp Eye Res. 1997; 64: 727–735
   PubMed Web of Science ®Google Scholar
• Chiarugi A, Rapizzi E, Moroni F, Moroni F. The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound. FEBS Lett. 1999; 453: 197–200
   Google Scholar
• Wood A M, Truscott R J. UV filters in human lenses: tryptophan catabolism. Exp Eye Res. 1993; 56: 317–325
   PubMed Web of Science ®Google Scholar
• Malina H Z, Martin X D. Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye. Graefes Arch Clin Exp Ophthalmol. 1996; 234: 457–462
   PubMedGoogle Scholar
• Stutchbury G M, Truscott R J. The modification of proteins by 3-hydroxykynurenine. Exp Eye Res. 1993; 57: 149–155
   PubMedGoogle Scholar
• Takikawa O, Littlejohn T K, Truscott R J. Indoleamine 2,3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters. Exp Eye Res. 2001; 72: 271–277
   PubMed Web of Science ®Google Scholar
• Eastman C L, Guilarte T R. Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res. 1989; 495: 225–231
   PubMed Web of Science ®Google Scholar
• Serbecic N, Beutelspacher S C. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage. Exp Eye Res. 2006; 82: 416–426
   PubMedGoogle Scholar
• Perkins M N, Stone T W. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 1982; 247: 184–187
   PubMed Web of Science ®Google Scholar
• Turski W A, Nakamura M, Todd W P, Carpenter B K, Whetsell W O, Schwarcz R. Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 1988; 545: 164–169
   Google Scholar
• Żarnowski T, Rejdak R, Zagórski Z, et al. Content of kynurenic acid and activity of kynurenine aminotransferases in mammalian eyes. Ophthalmic Res. 2004; 36: 124–128
   Google Scholar
• Milart P, Urbanska E M, Turski W A, et al. Kynurenine aminotransferase I activity in human placenta. Placenta 2001; 22: 259–261
   PubMedGoogle Scholar
• Stazka J, Luchowski P, Wielosz M, et al. Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine. Eur J Pharmacol. 2002; 448: 133–137
   PubMedGoogle Scholar
• Andine P, Lehmann A, Ellren K, et al. The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett. 1988; 90: 208–212
   PubMed Web of Science ®Google Scholar
• Stone T W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol. 2001; 64: 185–218
   PubMed Web of Science ®Google Scholar
• Okuno E, Du F, Ishikawa T, et al. Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain. Brain Res. 1990; 534: 37–44
   Google Scholar
• Rejdak R, Żarnowski T, Turski W A, et al. Presence of kynurenic acid and kynurenine aminotransferases in the inner retina. Neuroreport. 2001; 12: 3675–3678
   Google Scholar
• Zsizsik B K, Hardeland R. Formation of kynurenic acid and xanthurenic acid from kynurenine and 3-hydroxykynurenine in the dinoflagellatae Lingulodinum polyedrum: role of a novel, oxidative pathway. Comp Biochem Physiol C Toxicol Pharmacol. 2002; 133: 383–392
   Google Scholar
• Andrzejewska-Buczko J, Pawlak D, Tankiewicz A, et al. Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients. Med Sci Monitor. 2001; 7: 742–745
   PubMedGoogle Scholar
• Chylack L T, Wolfe J K, Singer D M, et al. The lens opacities classification system III. Arch Ophthalmol. 1993; 111: 831–836
   PubMed Web of Science ®Google Scholar
• Shibata R. Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography. J Chromatogr. 1988; 430: 376–380
   PubMedGoogle Scholar
• Guidetti P, Okuno E, Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res. 1997; 50: 457–465
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosenbrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Streete I M, Jamie J F, Truscott R J. Lenticular levels of amino acids and free UV filters differ significantly between normals and cataract patients. Invest Ophthalmol Vis Sci. 2004; 45: 4091–4098
   PubMedGoogle Scholar
• Roberts R C, Wishart J F, Martinez L, Chignell C F. Photochemical studies on xanthurenic acid. Photochem Photobiol. 2000; 72: 467–471
   Google Scholar
• Haines P G, Gao L, Truscott R J. The photosentisiser xanthurenic acid is not present in normal human lenses. Exp Eye Res. 2003; 77: 547–553
   Google Scholar
• Malina H Z, Martin X D. Indoleamino 2,3–dioxygenase activity is increased in the aqueous humor, iris/ciliary body and retina of the bovine eye. Graefes Arch Clin Exp Ophthalmol. 1993; 231: 482–486
   PubMed Web of Science ®Google Scholar
• Politi V, Lavaggi M V, Di Stazio G, Margonelli A. Indole-3-pyruvic acid as a direct precursor of kynurenic acid. Adv Exp Med Biol. 1991; 294: 515–518
   Google Scholar
• Taylor L M, Andrew Aquilina J, Jamie J F, Truscott R J. UV filter instability: consequences for the human lens. Exp Eye Res. 2002; 75: 165–175
   PubMedGoogle Scholar
• Vazques S, Parker N R, Sheil M, Truscott R J. Proteine-bound kynurenine decreases with the progression of age-related nuclear cataract. Invest Ophthalmol Vis Sci. 2004; 4: 879–883
   Google Scholar
• Wennersten G, Brunk U. Cellular aspects of phototoxic reactions induced by kynurenic acid. II. Fine structural analysis and cytochemistry on cultivated cells. Acta Derm Venereol. 1978; 58: 297–305
   Google Scholar
• Parker N R, Jamie J F, Davies M J, Truscott R J. Protein-bound kynurenine is a photosensitizer of oxidative damage. Free Radic Biol Med. 2004; 1: 1479–1489
   Google Scholar